Johnson & Johnson logo

Johnson & Johnson

JNJ | NYSE
Chart Builder DCF Calculator
$268.58
-$0.89 (-0.33%)
Sep 22, 2026, 10:49 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 27, 2025
FY 2024
Dec 28, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 31, 2022
FY 2021
Jan 1, 2022
FY 2020
Jan 2, 2021
Revenue
94.19B 88.82B 85.16B 79.99B 78.74B 82.58B
Cost of Revenue
25.64B 27.47B 26.55B 24.6B 23.4B 28.43B
Gross Profit
68.56B 61.35B 58.61B 55.39B 55.34B 54.16B
Operating Income
25.6B 22.15B 23.41B 21.01B 20.94B 19.73B
Interest Income
1.06B 1.33B 1.26B 490M 53M 111M
Pretax Income
32.58B 16.69B 15.06B 19.36B 19.18B 16.5B
Net Income
26.8B 14.07B 35.15B 17.94B 20.88B 14.71B
Selling & General & Admin
23.68B 21.97B 20.11B 20.25B 20.12B 22.08B
Research & Development
14.67B 17.23B 15.09B 14.14B 14.28B 12.34B
Other Expenses
4.62B n/a n/a n/a n/a n/a
Operating Expenses
42.96B 39.2B 35.2B 34.38B 34.4B 34.42B
Interest Expense
971M 755M 772M 276M 183M 201M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
68.6B 66.67B 61.75B 58.98B 57.8B 62.85B
Income Tax Expense
5.78B 2.62B 1.74B 2.99B 1.38B 1.78B
Shares Outstanding (Basic)
2.43B 2.41B 2.53B 2.61B 2.63B 2.63B
Shares Outstanding (Diluted)
2.43B 2.43B 2.56B 2.66B 2.67B 2.67B
EPS (Basic)
11.03 5.84 13.88 6.83 7.93 5.59
EPS (Diluted)
11.03 5.79 13.72 6.73 7.81 5.51
EBITDA
41.06B 24.78B 23.32B 26.61B 26.75B 23.93B
EBIT
33.55B 17.44B 15.83B 19.64B 19.36B 16.7B
Depreciation & Amortization
7.5B 7.34B 7.49B 6.97B 7.39B 7.23B

© 2026 bestshares.com. All rights reserved.